What You Should Know: – Outpace Bio, a pioneering cell therapy company raises $144M in oversubscribed Series B financing round led by RA Capital Management with participation from both new and existing investors, including…
Continue Reading
Period-tracking app Flo Health garnered more than $200 million in Series C funding from growth investor General Atlantic, bringing the women’s health company to unicorn status with a more than $1 billion valuation. Tanzeen Syed,…
Continue Reading
Medical technology company Imperative Care announced it initially closed an oversubscribed Series E financing round led by Ally Bridge Group. The company says additional closings of the round could bring its Series E up…
Continue Reading
Nomad Health, which offers an online job portal for temporary healthcare workers, announced it has secured $22 million.HealthQuest Capital led the round, with participation from Icon Ventures, Adams Street, .406 Ventures, RRE Ventures and…
Continue Reading
Roy Schoenberg, M.D., M.P.H, Executive Vice Chairman of the Board
What You Should Know:
– Amwell announced a significant leadership transition. Co-founder and visionary healthcare technology leader Roy Schoenberg, M.D., M.P.H., will transition from his role…
Continue Reading
Divita is a Certified Public Accountant and a member of the Florida Institute of Certified Public Accountants.
Photo: Courtesy of Teladoc
Virtual care company Teladoc Health’s Board of Directors has appointed Charles “Chuck” Divita III as…
What You Should Know:
Charles “Chuck” Divita, CEO at Teladoc Health
– Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, has announced the appointment of Charles “Chuck” Divita, III, as Chief…
Continue Reading
What You Should Know:
– Nucleus RadioPharma, the world’s first comprehensive radiopharmaceutical organization, today announced the closing of an extended Series A funding round with the addition of new investor AstraZeneca.
– The strategic investment bolsters…
Continue Reading
California-based real-world data platform Atropos Health has secured $33 million in Series B funding.Valtruis led the investment round, which included new investors McKesson Ventures, Merck GHI Fund and Cencora Ventures.
Existing investors Emerson Collective, Breyer…
Sameer Sabir, Chief Executive Officer of Brixton Biosciences
What You Should Know:
– Brixton Biosciences, a clinical-stage life sciences company focused on innovative pain treatments raises $33M in Series B funding led by Schooner Capital with…
Continue Reading
